X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
Investing in India? Get Equitymaster Research  
Midcaps, smallcaps buck trend 
(Wed, 24 Aug 11:30 am) 
 
Indian stock market indices continued to trade weak during the previous two hours of trade on the back of persistent selling across heavyweights. While stocks from the consumer durables and healthcare space are finding favour, IT stocks are at the receiving end.

The BSE-Sensex is down by 74 points and NSE-Nifty is down by 18 points at the moment. BSE-Midcap and BSE-Small cap indices are up by 0.56% and 0.77% respectively. The rupee is trading at 45.74 to the US dollar.

Retailing stocks are trading mixed. While Koutons Retail and Zodiac Clothing are in the green, Trent and Pantaloon are trading weak. As per a leading financial daily, Titan Industries, the watches to jewellery maker, is exploring options of getting into newer product lines. It aims to become a full fledged lifestyle retailing chain. As per the management, the objective is to enter new verticals every second year and try and gain leadership there. The retailing company has in the past gotten into fashion accessories like belts and sunglasses. It wants to position itself as a one stop shop for all lifestyle customer requirements ranging from watches to leather accessories to footwear. This year, the company is planning to launch silver watches and helmets. It may be noted that the company has been opening more and more stores across India for its watches, jewellery as well as fashion merchandise.

Pharma stocks are trading in the green. Lupin and Ranbaxy are the biggest gainers, while Glenmark and Sun Pharma are the biggest losers. According to a leading financial daily, Aventis Pharma, the 50% subsidiary of Sanofi-Aventis SA, France is close to buying the over the counter (OTC) business of Universal Medicare Limited for Rs 5 bn. Sanofi's OTC business in India is quite low and this deal will give boost to the French company's OTC business in India. The products included in the deal have annual sales of Rs 10 to 15 bn and the OTC segment is expected to grow at 17% to 18%, much higher than the expected growth of the overall pharmaceutical sector. The deal covers 30 brands sold by India based Universal Medicare and is expected to be signed in a couple of days.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives  RSS
Read the latest Market Commentary
 
BSE-30
 

 
Go
 

Equitymaster requests your view! Post a comment on "Midcaps, smallcaps buck trend". Click here!

  
 

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Aug 17, 2017 (Close)

MARKET STATS